In its latest transformative global transaction, Sullivan & Cromwell assisted Haleon PLC in its spin-off from the GSK Group. The deal not only created the world's biggest stand-alone consumer health company, but is the biggest European listing in more than a decade.
The transaction was executed as a demerger of 80 percent of GlaxoSmithKline's interest in Haleon, with holders of GSK shares or American Depository Shares receiving Haleon ordinary shares at a one-for-one ratio. Haleon's ordinary shares now trade on a stand-alone basis on the main market of the London Stock Exchange and its ADSs trade on the New York Stock Exchange.
Haleon is a leading consumer healthcare business with products including Advil, Theraflu and Tums. Formerly known as GSK Consumer Healthcare, the company was a joint venture between GSK and Pfizer, with GSK holding a controlling interest of 68 percent.
Haleon was advised by a cross-border team of S&C lawyers in New York and London, including Frank Aquila, Audra Cohen, John Horsfield-Bradbury, Jim Simpson, Susan Lindsay and Nitish Verma. Eric Wang, John Jo and Ellen Kim advised on U.S. tax matters.
Sullivan & Cromwell led all law firm advisers in global M&A deals announced in the first half of 2022 measured by value, according to Refinitiv. The Firm advised on $356 billion in M&A deals, retaining the top spot from 2021 and representing a 16 percent market share.
Subscribe to stay current on developments in M&A and Healthcare & Life Sciences.
Recent Publications and Podcasts:
- Senior M&A Partner Frank Aquila Authors 'ESG-Driven Divestments' for Practical Law
- ESG Trends and Hot Topics
- Frank Aquila Discusses Shifting M&A Landscape with The American Lawyer
- S&C Critical Insights – Episode 2: Implications of SEC's Proposed Climate-Related Disclosure Rules
- S&C Critical Insights – Episode 1: Implications of SEC's Proposed Climate-Related Disclosure Rules
- S&C Critical Insights – 2021 U.S. Shareholder Activism in Review and a Look Ahead
You may share a link to this page on any of the sites listed below.
This page has been added to your binder.
Continue Browsing | View Binder
In order to use the binder you must agree to cookie use.
Allow | Continue Browsing
Please enter a search term or select a suggested term from the list.
Close Window
Please select at least one search parameter or enter a keyword.
Close Window
This search term may not be submitted alone. Please adjust your search and try again.
Close Window
All pages were removed from your binder
You may not collect more than 75 pages in a binder. Feel free to generate this binder, clear it, and start a new one with the additional pages you wish to collect.
Close Window | View Binder
